Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Jetstream NAVITUS™ System Endovascular Therapy Post-market Registry (JET)

NCT01436435 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01436435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01436435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Jetstream NAVITUS™ System Endovascular Therapy Post-market Registry (JET)
Lead sponsor
Boston Scientific Corporation
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
February 29, 2016
Enrollment
241 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial diseases